Comparison Chart Vaxart, Inc.

Stocks

VXRT

US92243A2006

Biotechnology & Medical Research

Market Closed - OTC Markets 23:59:59 30/10/2026 +04			5-day change	1st Jan Change
0.4300 ^USD	+1.27%		+4.88%	+24.13%

10-19	Vaxart, Inc. Announces Appointment of Raquel C. Bono as Director, Chair of the Stockholder Engagement Committee, and Member of the Nominating and Governance Committee and the Clinical and Regulatory Affairs Committee	CI
10-08	Vaxart, Inc. Announces Publication of Preclinical Study Results Evaluating Its Adenovirus-Based Oral Mucosal Vaccine Platform Against H5N1	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	VAXART, INC.	Bio Therapeutic Drugs	+1.27%	+4.88%	+24.13%	+22.25%	-93.59%	105M	-	-	-